CN111393425B - 6-氟-3-哌啶-4-基-1,2-苯并异噁唑盐酸盐的制备方法 - Google Patents
6-氟-3-哌啶-4-基-1,2-苯并异噁唑盐酸盐的制备方法 Download PDFInfo
- Publication number
- CN111393425B CN111393425B CN201910000968.7A CN201910000968A CN111393425B CN 111393425 B CN111393425 B CN 111393425B CN 201910000968 A CN201910000968 A CN 201910000968A CN 111393425 B CN111393425 B CN 111393425B
- Authority
- CN
- China
- Prior art keywords
- alcohol
- reaction
- hydrochloride
- water
- fluoro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- CWPSRUREOSBKBQ-UHFFFAOYSA-N 6-fluoro-3-piperidin-4-yl-1,2-benzoxazole;hydrochloride Chemical compound Cl.N=1OC2=CC(F)=CC=C2C=1C1CCNCC1 CWPSRUREOSBKBQ-UHFFFAOYSA-N 0.000 title claims abstract description 14
- 238000002360 preparation method Methods 0.000 title abstract description 16
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 38
- 238000006243 chemical reaction Methods 0.000 claims abstract description 35
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 claims abstract description 34
- 238000000034 method Methods 0.000 claims abstract description 34
- 238000001914 filtration Methods 0.000 claims abstract description 27
- 238000010438 heat treatment Methods 0.000 claims abstract description 25
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims abstract description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 18
- 238000001035 drying Methods 0.000 claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 18
- QPJONRGTWKXJLG-UHFFFAOYSA-N (2,4-difluorophenyl)-piperidin-4-ylmethanone;hydrochloride Chemical compound Cl.FC1=CC(F)=CC=C1C(=O)C1CCNCC1 QPJONRGTWKXJLG-UHFFFAOYSA-N 0.000 claims abstract description 17
- 238000007363 ring formation reaction Methods 0.000 claims abstract description 17
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims abstract description 12
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000012074 organic phase Substances 0.000 claims abstract description 8
- 150000003839 salts Chemical class 0.000 claims abstract description 7
- MSXVEPNJUHWQHW-UHFFFAOYSA-N 2-methyl-2-butanol Substances CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000003513 alkali Substances 0.000 claims abstract description 6
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 claims abstract description 4
- 238000002156 mixing Methods 0.000 claims abstract description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 72
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 15
- 239000002585 base Substances 0.000 claims description 9
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 8
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 4
- 238000001953 recrystallisation Methods 0.000 claims description 2
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 claims description 2
- 239000012535 impurity Substances 0.000 abstract description 43
- 238000004321 preservation Methods 0.000 abstract description 17
- MRMGJMGHPJZSAE-UHFFFAOYSA-N 6-fluoro-3-piperidin-4-yl-1,2-benzoxazole Chemical compound N=1OC2=CC(F)=CC=C2C=1C1CCNCC1 MRMGJMGHPJZSAE-UHFFFAOYSA-N 0.000 abstract description 6
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 5
- 239000002699 waste material Substances 0.000 abstract description 5
- 238000005580 one pot reaction Methods 0.000 abstract description 4
- 150000002923 oximes Chemical class 0.000 description 21
- 238000005070 sampling Methods 0.000 description 20
- 239000000243 solution Substances 0.000 description 19
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 16
- 239000000047 product Substances 0.000 description 16
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 14
- 239000002994 raw material Substances 0.000 description 14
- 238000001816 cooling Methods 0.000 description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 10
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 10
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- 239000012044 organic layer Substances 0.000 description 8
- 239000010410 layer Substances 0.000 description 7
- 239000002904 solvent Substances 0.000 description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 5
- -1 oxime hydrochloride Chemical class 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 3
- FUKUFMFMCZIRNT-UHFFFAOYSA-N hydron;methanol;chloride Chemical compound Cl.OC FUKUFMFMCZIRNT-UHFFFAOYSA-N 0.000 description 3
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- LFVGISIMTYGQHF-UHFFFAOYSA-N ammonium dihydrogen phosphate Chemical compound [NH4+].OP(O)([O-])=O LFVGISIMTYGQHF-UHFFFAOYSA-N 0.000 description 2
- 229910000387 ammonium dihydrogen phosphate Inorganic materials 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000019837 monoammonium phosphate Nutrition 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- PMXMIIMHBWHSKN-UHFFFAOYSA-N 3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one Chemical compound FC1=CC=C2C(C3CCN(CC3)CCC=3C(=O)N4CCCC(O)C4=NC=3C)=NOC2=C1 PMXMIIMHBWHSKN-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229960003162 iloperidone Drugs 0.000 description 1
- XMXHEBAFVSFQEX-UHFFFAOYSA-N iloperidone Chemical compound COC1=CC(C(C)=O)=CC=C1OCCCN1CCC(C=2C3=CC=C(F)C=C3ON=2)CC1 XMXHEBAFVSFQEX-UHFFFAOYSA-N 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- DAQWROFRHWHKFE-UHFFFAOYSA-N n-[(2,4-difluorophenyl)-piperidin-4-ylmethylidene]hydroxylamine Chemical compound C=1C=C(F)C=C(F)C=1C(=NO)C1CCNCC1 DAQWROFRHWHKFE-UHFFFAOYSA-N 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 238000006146 oximation reaction Methods 0.000 description 1
- 229960001057 paliperidone Drugs 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
时间(分钟) | 流动相A(%) | 流动相B(%) |
0 | 100 | 0 |
10 | 100 | 0 |
15 | 60 | 40 |
30 | 60 | 40 |
环合反应时间 | 羟基杂质 | 丁氧基杂质 | 纯度 |
6小时 | 0.57% | 未检出 | 97.86% |
7小时 | 0.57% | 未检出 | 98.06% |
23小时 | 0.55% | 未检出 | 98.46% |
成盐后得到的产品 | 0.02% | 未检出 | 99.66% |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910000968.7A CN111393425B (zh) | 2019-01-02 | 2019-01-02 | 6-氟-3-哌啶-4-基-1,2-苯并异噁唑盐酸盐的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910000968.7A CN111393425B (zh) | 2019-01-02 | 2019-01-02 | 6-氟-3-哌啶-4-基-1,2-苯并异噁唑盐酸盐的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111393425A CN111393425A (zh) | 2020-07-10 |
CN111393425B true CN111393425B (zh) | 2021-11-26 |
Family
ID=71428287
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910000968.7A Active CN111393425B (zh) | 2019-01-02 | 2019-01-02 | 6-氟-3-哌啶-4-基-1,2-苯并异噁唑盐酸盐的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111393425B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101328173A (zh) * | 2008-07-31 | 2008-12-24 | 石药集团欧意药业有限公司 | 一种制备6-氟-3-(4-哌啶基)-1,2-苯并异噁唑盐酸盐的方法 |
CN102206210A (zh) * | 2011-04-01 | 2011-10-05 | 常州市第四制药厂有限公司 | 一种6-氟-3-(4-哌啶基)-1,2-苯并异噁唑盐酸盐的生产方法 |
CN102796090A (zh) * | 2012-08-30 | 2012-11-28 | 天津华津制药有限公司 | 一种伊潘立酮的制备方法 |
-
2019
- 2019-01-02 CN CN201910000968.7A patent/CN111393425B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101328173A (zh) * | 2008-07-31 | 2008-12-24 | 石药集团欧意药业有限公司 | 一种制备6-氟-3-(4-哌啶基)-1,2-苯并异噁唑盐酸盐的方法 |
CN102206210A (zh) * | 2011-04-01 | 2011-10-05 | 常州市第四制药厂有限公司 | 一种6-氟-3-(4-哌啶基)-1,2-苯并异噁唑盐酸盐的生产方法 |
CN102796090A (zh) * | 2012-08-30 | 2012-11-28 | 天津华津制药有限公司 | 一种伊潘立酮的制备方法 |
Non-Patent Citations (1)
Title |
---|
利培酮的合成;陆学华,等;《中国药物化学杂志》;20070430;第17卷(第2期);第90-91页 * |
Also Published As
Publication number | Publication date |
---|---|
CN111393425A (zh) | 2020-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP44A (en) | Azithromycin dihydrate | |
CN108794491B (zh) | 一种枸橼酸托法替布的精制方法 | |
CN113214239B (zh) | 特地唑胺的精制工艺及磷酸特地唑胺的制备方法 | |
CN109563102A (zh) | 生物素的中间体的制造方法、及生物素的制造方法 | |
WO2021259203A1 (zh) | 一种cdk4/6抑制剂的制备方法 | |
CN109867673B (zh) | 一种合成帕布昔利布的方法 | |
CN114957101A (zh) | 一种3-芳基取代二哌啶酮及尼拉帕利的合成方法 | |
CN111393425B (zh) | 6-氟-3-哌啶-4-基-1,2-苯并异噁唑盐酸盐的制备方法 | |
EP2935255A1 (en) | A process for preparation of rivaroxaban | |
EP4046687A1 (en) | Method for producing centanafadine | |
CN111302953B (zh) | 一种合成亚精胺盐酸盐的方法 | |
CN105503854A (zh) | 一种达沙替尼无水合物的新晶型物及其制备方法 | |
CN111559968B (zh) | 一种拉考沙胺晶型ii的制备方法 | |
CN107540625B (zh) | 一种利奈唑胺的制备方法 | |
CN111116593B (zh) | 一种连续的伊鲁替尼的制备方法 | |
CN104876812B (zh) | 制备盐酸舍曲林中间体及杂质的方法 | |
CN109280011B (zh) | Oled中间体2-溴芘的合成法 | |
CN114315703B (zh) | 一种高纯度的维生素b6的制备方法 | |
CN113135897B (zh) | 一种富马酸卢帕他定b晶型及其制备方法 | |
CN110386928B (zh) | 一种阿齐沙坦合成工艺 | |
CN111171001B (zh) | 一种parp抑制剂中间体的结晶方法 | |
CN109467512B (zh) | 一种3,4-二氨基-二苯甲酮的合成方法 | |
CN111100093B (zh) | 一种Cytoxazone及其中间体的制备方法 | |
CN106397403A (zh) | 一种达比加群酯甲磺酸盐中间体的纯化方法 | |
CN112608286B (zh) | 一种高纯度普拉克索的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: No. 800, East Xinchang Avenue, Yulin street, Xinchang County, Shaoxing City, Zhejiang Province 312500 Patentee after: ZHEJIANG JINGXIN PHARMACEUTICAL Co.,Ltd. Country or region after: China Patentee after: Shaoxing Jingxin Pharmaceutical Co.,Ltd. Address before: No. 800, East Xinchang Avenue, Yulin street, Xinchang County, Shaoxing City, Zhejiang Province 312500 Patentee before: ZHEJIANG JINGXIN PHARMACEUTICAL Co.,Ltd. Country or region before: China Patentee before: SHANGYU JINGXIN PHARMACEUTICAL Co.,Ltd. |
|
CP03 | Change of name, title or address |